Abstract
The 25-hydroxy vitamin D (25(OH)D) production caused by UVB exposure is usually underestimated as the concurrent degradation of 25(OH)D is not considered. Therefore, the decrease in 25(OH)D was investigated during a 7-week period in winter when ambient UVB is negligible. Twenty-two healthy Danish individuals (113 samples) participated and had a mean and steady maximal 25(OH)D start level of 132 nmol l−1 (range of 68–216 nmol l−1) due to long-term UVB treatment prior to this study. In this group with high 25(OH)D start levels, the decrease in 25(OH)D was best described by an exponential model. This suggests a quantitatively larger elimination of 25(OH)D at high 25(OH)D start levels. A linear model (logarithm of 25(OH)D) including personal start levels as intercepts and a slope influenced by gender and the vitamin D receptor gene polymorphism rs2228570 explained 87.8% of the observed variation. The mean half-life was 89 days with a difference in half-life of 120 days between a male with rs2228570 genotype GG (59 days) and a female with rs2228570 genotype AA/AG (179 days). Thus, these two parameters explained a large part of the observed inter-individual variation of 25(OH)D. Furthermore, the decrease was analysed in two groups with medium and low 25(OH)D start levels resulting in longer half-lives of 149 days and 199 days, respectively. The longer half-lives at lower 25(OH)D levels may be caused by storage mobilisation, changed catabolism or increased intestinal absorption.
Similar content being viewed by others
References
A. C. Ross, J. E. Manson, S. A. Abrams, J. F. Aloia, P. M. Brannon, S. K. Clinton, R. A. Durazo-Arvizu, J. C. Gallagher, R. L. Gallo, G. Jones, C. S. Kovacs, S. T. Mayne, C. J. Rosen and S. A. Shapses, The 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine: what clinicians need to know, J. Clin. Endocrinol. Metab., 2011, 96, 53–58.
M. F. Holick, T. C. Chen, Z. Lu and E. Sauter, Vitamin D and skin physiology: a D-lightful story, J. Bone Miner. Res., 2007, 22, V28–V33.
M. F. Holick, Vitamin D deficiency, N. Engl. J. Med., 2007, 357, 266–281.
M. F. Holick, N. C. Binkley, H. A. Bischoff-Ferrari, C. M. Gordon, D. A. Hanley, R. P. Heaney, M. H. Murad and C. M. Weaver, Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline, J. Clin. Endocrinol. Metab., 2011, 96, 1911–1930.
J. B. Cheng, D. L. Motola, D. J. Mangelsdorf and D. W. Russell, De-orphanization of cytochrome P450 2R1: a microsomal vitamin D 25-hydroxilase, J. Biol. Chem., 2003, 278, 38084–38093.
J. B. Cheng, M. A. Levine, N. H. Bell, D. J. Mangelsdorf and D. W. Russell, Genetic evidence that the human CYP2R1 enzyme is a key vitamin D 25-hydroxylase, Proc. Natl. Acad. Sci. U. S. A., 2004, 101, 7711–7715.
D. E. Lawson, D. R. Fraser, E. Kodicek, H. R. Morris and D. H. Williams, Identification of 1, 25-dihydroxycholecalciferol, a new kidney hormone controlling calcium metabolism, Nature, 1971, 230, 228–230.
D. D. Bikle, Vitamin D metabolism, mechanism of action, and clinical applications, Chem. Biol., 2014, 21, 319–329.
A. J. Batchelor and J. E. Compston, Reduced plasma half-life of radio-labelled 25-hydroxyvitamin D3 in subjects receiving a high-fibre diet, Br. J. Nutr., 1983, 49, 213–216.
M. R. Clements, M. Davies, D. R. Fraser, G. A. Lumb, E. B. Mawer and P. H. Adams, Metabolic inactivation of vitamin D is enhanced in primary hyperparathyroidism, Clin. Sci., 1987, 73, 659–664.
K. S. Jones, I. Schoenmakers, L. J. Bluck, S. Ding and A. Prentice, Plasma appearance and disappearance of an oral dose of 25-hydroxyvitamin D2 in healthy adults, Br. J. Nutr., 2012, 107, 1128–1137.
D. E. Prosser and G. Jones, Enzymes involved in the activation and inactivation of vitamin D, Trends Biochem. Sci., 2004, 29, 664–673.
G. Jones, S. A. Strugnell and H. F. DeLuca, Current understanding of the molecular actions of vitamin D, Physiol. Rev., 1998, 78, 1193–1231.
G. Jones, D. E. Prosser and M. Kaufmann, Cytochrome P450-mediated metabolism of vitamin D, J. Lipid Res., 2014, 55, 13–31.
J. D. Lindh, L. Bjorkhem-Bergman and E. Eliasson, Vitamin D and drug-metabolising enzymes, Photochem. Photobiol. Sci., 2012, 11, 1797–1801.
T. Sakaki, N. Sawada, Y. Nonaka, Y. Ohyama and K. Inouye, Metabolic studies using recombinant escherichia coli cells producing rat mitochondrial CYP24 CYP24 can convert 1alpha, 25-dihydroxyvitamin D3 to calcitroic acid, Eur. J. Biochem., 1999, 262, 43–48.
T. Sakaki, N. Sawada, K. Komai, S. Shiozawa, S. Yamada, K. Yamamoto, Y. Ohyama and K. Inouye, Dual metabolic pathway of 25-hydroxyvitamin D3 catalyzed by human CYP24, Eur. J. Biochem., 2000, 267, 6158–6165.
M. K. Bogh, A. V. Schmedes, P. A. Philipsen, E. Thieden and H. C. Wulf, A small suberythemal UVB dose every second week is sufficient to maintain summer vitamin D levels: a randomized controlled trial, Br. J. Dermatol., 2011, 166, 430–433.
M. K. Bogh, A. V. Schmedes, P. A. Philipsen, E. Thieden and H. C. Wulf, Vitamin D production after UVB exposure depends on baseline vitamin D and total cholesterol but not on skin pigmentation, J. Invest. Dermatol., 2010, 26, 546–553.
M. D. Farrar, A. R. Webb, R. Kift, M. T. Durkin, D. Allan, A. Herbert, J. L. Berry and L. E. Rhodes, Efficacy of a dose range of simulated sunlight exposures in raising vitamin D status in South Asian adults: implications for targeted guidance on sun exposure, Am. J. Clin. Nutr., 2013, 97, 1210–1216.
M. D. Farrar, R. Kift, S. J. Felton, J. L. Berry, M. T. Durkin, D. Allan, A. Vail, A. R. Webb and L. E. Rhodes, Recommended summer sunlight exposure amounts fail to produce sufficient vitamin D status in UK adults of South Asian origin, Am. J. Clin. Nutr., 2011, 94, 1219–1224.
R. McKenzie, R. Scragg, B. Liley, P. Johnston, J. Wishart, A. Stewart and R. Prematunga, Serum 25-hydroxyvitamin-D responses to multiple UV exposures from solaria: inferences for exposure to sunlight, Photochem. Photobiol. Sci., 2012, 11, 1174–1185.
P. Datta, P. A. Philipsen, P. Olsen, B. Petersen, P. Johansen, N. Morling and H. C. Wulf, Major inter-personal variation in the increase and maximal level of 25-hydroxy vitamin D induced by UVB, Photochem. Photobiol. Sci., 2016, 15, 536–545.
W. Becker, N. Lyhne, A. N. Pedersen, A. Aro, M. Fogelholm, I. Phorsdottir, J. Alexander, S. A. Anderssen, H. M. Meltzer and J. I. Pedersen, Nordic Nutrition Recommendations 2004 - integrating nutrition and physical activity, Scand. J. Nutr., 2004, 48, 178–187.
C. Brot, P. Vestergaard, N. Kolthoff, J. Gram, A. P. Hermann and O. H. Sorensen, Vitamin D status and its adequacy in healthy Danish perimenopausal women: relationships to dietary intake, sun exposure and serum parathyroid hormone, Br. J. Nutr., 2001, 86 Suppl 1, S97–103.
P. Datta, M. K. Bogh, P. Olsen, P. Eriksen, A. V. Schmedes, M. M. Grage, P. A. Philipsen and H. C. Wulf, Increase in serum 25-hydroxyvitamin-D(3) in humans after solar exposure under natural conditions compared to artificial UVB exposure of hands and face, Photochem. Photobiol. Sci., 2012, 11, 1817–1824.
M. K. Bogh, A. V. Schmedes, P. A. Philipsen, E. Thieden and H. C. Wulf, Interdependence between body surface area and ultraviolet B dose in vitamin D production: a randomized controlled trial, Br. J. Dermatol., 2011, 164, 163–169.
S. S. Harris, B. Dawson-Hughes, Seasonal changes in plasma 25-hydroxyvitamin D concentrations of young American black and white women, Am. J. Clin. Nutr., 1998, 67, 1232–1236.
J. I. Pedersen, Vitamin D requirement and setting recommendation levels - current Nordic view, Nutr. Rev., 2008, 66, S165–S169.
S. A. Rice, M. Carpenter, A. Fityan, L. M. Vearncombe, M. Ardern-Jones, A. A. Jackson, C. Cooper, J. Baird and E. Healy, Limited exposure to ambient ultraviolet radiation and 25-hydroxyvitamin D levels: a systematic review, Br. J. Dermatol., 2015, 172, 652–661.
G. Jones, D. E. Prosser and M. Kaufmann, 25-Hydroxyvitamin D-24-hydroxylase (CYP24A1): its important role in the degradation of vitamin D, Arch. Biochem. Biophys., 2012, 523, 9–18.
Y. Xu, T. Hashizume, M. C. Shuhart, C. L. Davis, W. L. Nelson, T. Sakaki, T. F. Kalhorn, P. B. Watkins, E. G. Schuetz and K. E. Thummel, Intestinal and hepatic CYP3A4 catalyze hydroxylation of 1alpha, 25-dihydroxyvitamin D(3): implications for drug-induced osteomalacia, Mol. Pharmacol., 2006, 69, 56–65.
Z. Wang, Y. S. Lin, X. E. Zheng, T. Senn, T. Hashizume, M. Scian, L. J. Dickmann, S. D. Nelson, T. A. Baillie, M. F. Hebert, D. Blough, C. L. Davis and K. E. Thummel, An inducible cytochrome P450 3A4-dependent vitamin D catabolic pathway, Mol. Pharmacol., 2012, 81, 498–509.
S. Christakos, P. Dhawan, A. Verstuyf, L. Verlinden and G. Carmeliet, Vitamin D: Metabolism, Molecular Mechanism of Action, and Pleiotropic Effects, Physiol. Rev., 2016, 96, 365–408.
C. Zierold, G. G. Reinholz, J. A. Mings, J. M. Prahl and H. F. DeLuca, Regulation of the procine 1, 25-dihydroxyvitamin D3-24-hydroxylase (CYP24) by 1, 25-dihydroxyvitamin D3 and parathyroid hormone in AOK-B50 cells, Arch. Biochem. Biophys., 2000, 381, 323–327.
C. Zierold, J. A. Mings and H. F. DeLuca, Parathyroid hormone regulates 25-hydroxyvitamin D(3)-24-hydroxylase mRNA by altering its stability, Proc. Natl. Acad. Sci. U. S. A., 2001, 98, 13572–13576.
R. St-Arnaud, Targeted inactivation of vitamin D hydroxylases in mice, Bone, 1999, 25, 127–129.
S. Masuda, V. Byford, A. Arabian, Y. Sakai, M. B. Demay, R. St-Arnaud and G. Jones, Altered pharmacokinetics of 1alpha, 25-dihydroxyvitamin D3 and 25-hydroxyvitamin D3 in the blood and tissues of the 25-hydroxyvitamin D-24-hydroxylase (Cyp24a1) null mouse, Endocrinology, 2005, 146, 825–834.
S. J. Rosenstreich, C. Rich and W. Volwiler, Deposition in and release of vitamin D3 from body fat: evidence for a storage site in the rat, J. Clin. Invest., 1971, 50, 679–687.
R. P. Heaney, R. R. Recker, J. Grote, R. L. Horst and L. A. Armas, Vitamin D(3) is more potent than vitamin D(2) in humans, J. Clin. Endocrinol. Metab., 2011, 96, E447–E452.
D. A. Brouwer, B. J. van, H. Ferwerda, A. M. Brugman, F. R. van der Klis, H. J. van der Heiden and F. A. Muskiet, Rat adipose tissue rapidly accumulates and slowly releases an orally-administered high vitamin D dose, Br. J. Nutr., 1998, 79, 527–532.
M. Abboud, M. S. Rybchyn, R. Rizk, D. R. Fraser and R. S. Mason, Sunlight exposure is just one of the factors which influence vitamin D status, Photochem. Photobiol. Sci., 2017, 302–313.
P. Bec, F. Bayard and J. P. Louvet, 25-Hydroxycholecalciderol dynamics in human plasma, Rev. Eur. Etud. Clin. Biol., 1972, 17, 793–796.
R. W. Gray, H. P. Weber, J. H. Dominguez, J. Lemann Jr., The metabolism of vitamin D3 and 25-hydroxyvitamin D3 in normal and anephric humans, J. Clin. Endocrinol. Metab., 1974, 39, 1045–1056.
J. G. Haddad Jr. and S. Rojanasathit, Acute administration of 25-hydroxycholecalciferol in man, J. Clin. Endocrinol. Metab., 1976, 42, 284–290.
K. S. Jones, S. Assar, D. Harnpanich, R. Bouillon, D. Lambrechts, A. Prentice and I. Schoenmakers, 25(OH)D2 half-life is shorter than 25(OH)D3 half-life and is influenced by DBP concentration and genotype, J. Clin. Endocrinol. Metab., 2014, 99, 3373–3381.
K. S. Jones, S. Assar, D. Vanderschueren, R. Bouillon, A. Prentice and I. Schoenmakers, Predictors of 25(OH)D half-life and plasma 25(OH)D concentration in The Gambia and the UK, Osteoporosis Int., 2015, 26, 1137–1146.
E. B. Mawer, K. Schaefer, G. A. Lumb and S. W. Stanbury, The metabolism of isotopically labelled vitamin D3 in man: the influence of the state of vitamin D nutrition, Clin. Sci., 1971, 40, 39–53.
J. E. Smith and D. S. Goodman, The turnover and transport of vitamin D and of a polar metabolite with the properties of 25-hydroxycholecalciferol in human plasma, J. Clin. Invest., 1971, 50, 2159–2167.
D. Vicchio, A. Yergey, K. O’Brien, L. Allen, R. Ray and M. Holick, Quantification and kinetics of 25-hydroxyvitamin D3 by isotope dilution liquid chromatography/thermospray mass spectrometry, Biol. Mass Spectrom., 1993, 22, 53–58.
S. Christakos, D. V. Ajibade, P. Dhawan, A. J. Fechner and L. J. Mady, Vitamin D: metabolism, Rheum. Dis. Clin. North Am., 2012, 38, 1–11, vii.
P. Dhawan, X. Peng, A. L. Sutton, P. N. MacDonald, C. M. Croniger, C. Trautwein, M. Centrella, T. L. McCarthy and S. Christakos, Functional cooperation between CCAAT/enhancer-binding proteins and the vitamin D receptor in regulation of 25-hydroxyvitamin D3 24-hydroxylase, Mol. Cell Biol., 2005, 25, 472–487.
C. S. Hii and A. Ferrante, The Non-Genomic Actions of Vitamin D, Nutrients, 2016, 8, 135.
P. R. Ebeling, Vitamin D and bone health: Epidemiologic studies, BoneKEy Rep., 2014, 3, 511.
A. J. Berlanga-Taylor and J. C. Knight, An integrated approach to defining genetic and environmental determinants for major clinical outcomes involving vitamin d, Mol. Diagn. Ther., 2014, 18, 261–272.
G. P. Levin, C. Robinson-Cohen, I. H. de Boer, D. K. Houston, K. Lohman, Y. Liu, S. B. Kritchevsky, J. A. Cauley, T. Tanaka, L. Ferrucci, S. Bandinelli, K. V. Patel, E. Hagstrom, K. Michaelsson, H. Melhus, T. Wang, M. Wolf, B. M. Psaty, D. Siscovick and B. Kestenbaum, Genetic variants and associations of 25-hydroxyvitamin D concentrations with major clinical outcomes, J. Am. Med. Assoc., 2012, 308, 1898–1905.
T. J. Wang, F. Zhang, J. B. Richards, B. Kestenbaum, J. B. van Meurs, D. Berry, D. P. Kiel, E. A. Streeten, C. Ohlsson, D. L. Koller, L. Peltonen, J. D. Cooper, P. F. O’Reilly, D. K. Houston, N. L. Glazer, L. Vandenput, M. Peacock, J. Shi, F. Rivadeneira, M. I. McCarthy, P. Anneli, I. H. de Boer, M. Mangino, B. Kato, D. J. Smyth, S. L. Booth, P. F. Jacques, G. L. Burke, M. Goodarzi, C. L. Cheung, M. Wolf, K. Rice, D. Goltzman, N. Hidiroglou, M. Ladouceur, N. J. Wareham, L. J. Hocking, D. Hart, N. K. Arden, C. Cooper, S. Malik, W. D. Fraser, A. L. Hartikainen, G. Zhai, H. M. Macdonald, N. G. Forouhi, R. J. Loos, D. M. Reid, A. Hakim, E. Dennison, Y. Liu, C. Power, H. E. Stevens, L. Jaana, R. S. Vasan, N. Soranzo, J. Bojunga, B. M. Psaty, M. Lorentzon, T. Foroud, T. B. Harris, A. Hofman, J. O. Jansson, J. A. Cauley, A. G. Uitterlinden, Q. Gibson, M. R. Jarvelin, D. Karasik, D. S. Siscovick, M. J. Econs, S. B. Kritchevsky, J. C. Florez, J. A. Todd, J. Dupuis, E. Hypponen and T. D. Spector, Common genetic determinants of vitamin D insufficiency: a genome-wide association study, Lancet, 2010, 376, 180–188.
J. C. Gallagher, V. Yalamanchili and L. M. Smith, The effect of vitamin D supplementation on serum 25(OH)D in thin and obese women, J. Steroid Biochem. Mol. Biol., 2013, 136, 195–200.
P. Lee, J. R. Greenfield, M. J. Seibel, J. A. Eisman and J. R. Center, Adequacy of vitamin D replacement in severe deficiency is dependent on body mass index, Am. J. Med., 2009, 122, 1056–1060.
P. Saneei, A. Salehi-Abargouei and A. Esmaillzadeh, Serum 25-hydroxy vitamin D levels in relation to body mass index: a systematic review and meta-analysis, Obes. Rev., 2013, 14, 393–404.
J. R. Delanghe, R. Speeckaert and M. M. Speeckaert, Behind the scenes of vitamin D binding protein: more than vitamin D binding, Best. Pract. Res., Clin. Endocrinol. Metab., 2015, 29, 773–786.
C. E. Powe, M. K. Evans, J. Wenger, A. B. Zonderman, A. H. Berg, M. Nalls, H. Tamez, D. Zhang, I. Bhan, S. A. Karumanchi, N. R. Powe and R. Thadhani, Vitamin D-binding protein and vitamin D status of black Americans and white Americans, N. Engl. J. Med., 2013, 369, 1991–2000.
P. Yousefzadeh, S. A. Shapses and X. Wang, Vitamin D Binding Protein Impact on 25-Hydroxyvitamin D Levels under Different Physiologic and Pathologic Conditions, Int. J. Endocrinol., 2014, 2014, 981581.
A. R. Webb, L. Kline and M. F. Holick, Influence of season and latitude on the cutaneous synthesis of vitamin D3: exposure to winter sunlight in Boston and Edmonton will not promote vitamin D3 synthesis in human skin, J. Clin. Endocrinol. Metab., 1988, 67, 373–378.
T. B. Fitzpatrick, The validity and practicality of sun-reactive skin types I through VI, Arch. Dermatol., 1988, 124, 869–871.
H. C. Wulf, Method and an apparatus for determining an individual’s ability to stand exposure to ultraviolet radiation, America Patent and Trademark Office, US Patent4882598, 1986, 1–32
P. Armitage, G. Berry and J. N. S. Matthews, Statistical Methods in Medical Research, Wiley-Blackwell, 2001, ch. 11, pp.312–377
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Datta, P., Philipsen, P.A., Olsen, P. et al. The half-life of 25(OH)D after UVB exposure depends on gender and vitamin D receptor polymorphism but mainly on the start level. Photochem Photobiol Sci 16, 985–995 (2017). https://doi.org/10.1039/c6pp00258g
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1039/c6pp00258g